Sightfresh vs TheyaVue 2026: Which Eye Supplement Is Actually Better?
When comparing Sightfresh vs TheyaVue, Sightfresh holds a meaningful formula edge for most buyers focused on macular pigment support. Its Saffron Extract (20 mg) — the single ingredient with the strongest direct RCT evidence for photoreceptor function improvement in AMD patients — is absent from TheyaVue entirely. Sightfresh also delivers more Zeaxanthin (4 mg vs 2 mg) and adds NAC and Quercetin for antioxidant depth. TheyaVue counters with a well-dosed Grape Seed Extract (300 mg) for vascular support and a lower single-bottle entry price ($79 vs $69 for Sightfresh) — but across the critical macular carotenoid and photoreceptor-specific evidence categories, Sightfresh’s formula is more defensible.
TL;DR — Sightfresh vs TheyaVue 2026
- Sightfresh (Premvitality) includes Saffron Extract 20 mg — the only ingredient in either formula with randomized controlled trial evidence specifically for retinal ERG improvement in AMD patients
- TheyaVue (Gettheyavue) includes Grape Seed Extract 300 mg — a meaningful addition for retinal vascular support not found in Sightfresh
- Both deliver Lutein 20 mg and Bilberry Extract 160 mg; Sightfresh provides higher Zeaxanthin (4 mg vs 2 mg) and adds Eyebright, NAC, and Quercetin
- Sightfresh wins on photoreceptor-specific evidence (Saffron) and carotenoid density; TheyaVue wins on vascular polyphenol depth (Grape Seed Extract 300 mg)
- Sightfresh is $10 cheaper per bottle at single-bottle pricing ($69 vs $79); both reach parity at the 6-bottle tier ($49/bottle)
- Both offer 60-day money-back guarantees enforced through ClickBank’s independent buyer-protection infrastructure
- For buyers prioritizing the strongest photoreceptor-specific clinical evidence, Sightfresh is the recommended choice in this comparison
Check Current Sightfresh Pricing on the Official Website{rel=“nofollow sponsored”} — 60-day money-back guarantee
Quick Comparison Overview
The table below captures the most important variables for a first-pass evaluation of these two vision supplements. Detailed analysis of each category follows.
| Feature | Sightfresh | TheyaVue |
|---|---|---|
| Manufacturer | Premvitality | Gettheyavue |
| Lutein | 20 mg | 20 mg |
| Zeaxanthin | 4 mg | 2 mg |
| Bilberry Extract | 160 mg | 160 mg |
| Saffron Extract | 20 mg | Not present |
| Grape Seed Extract | Not present | 300 mg |
| Eyebright | 400 mg | Not present |
| NAC | 200 mg | Not present* |
| Quercetin | 500 mg | 100 mg† |
| Vitamin A | 5,000 IU | 10,000 IU |
| Zinc | 25 mg | 40 mg |
| Copper | 2 mg | 2 mg |
| Rutin | Not present | 100 mg |
| Price (1 bottle) | $69 | $79 |
| Price (3-pack) | $59/bottle | $59/bottle |
| Price (6-pack) | $49/bottle | $49/bottle |
| Guarantee | 60-day money-back | 60-day money-back |
| Distribution | ClickBank (Premvitality) | ClickBank (Gettheyavue) |
*TheyaVue’s formulation in some sources includes NAC 200 mg; verify current label on the official site. †TheyaVue’s Quercetin dose varies by lot; the 100 mg figure reflects the commonly reported formulation.
This overview tells the structural story: these two formulas share the same carotenoid quantity at Lutein, the same Bilberry dose, and the same 60-day guarantee infrastructure. The decisive differences are Saffron (present in Sightfresh, absent in TheyaVue), Grape Seed Extract (present in TheyaVue at 300 mg, absent in Sightfresh), Zeaxanthin dose (Sightfresh doubles TheyaVue’s 2 mg), and entry price ($10 cheaper per single bottle at Sightfresh).
For buyers who want the full clinical profile of Sightfresh before reading this comparison, our full Sightfresh Review covers the complete 90-day testing methodology and ingredient-by-trial cross-reference. The TheyaVue Review provides the equivalent depth for TheyaVue.
Ingredient Comparison Deep-Dive
This is the section that matters most. Every buying decision for a vision supplement should start with the ingredient panel and the clinical evidence for each ingredient at the stated dose.
Full Ingredient Comparison Table
| Ingredient | Sightfresh Dose | TheyaVue Dose | Clinical Evidence | Edge |
|---|---|---|---|---|
| Lutein | 20 mg | 20 mg | AREDS2 established 10 mg as clinically efficacious; both formulas exceed the minimum. MPOD increases are dose-dependent. PMID 23644932 | Tie (both at 2x AREDS2) |
| Zeaxanthin | 4 mg | 2 mg | Co-carotenoid concentrated at the foveal center. AREDS2 minimum is 2 mg; higher doses show greater MPOD increase. PMID 31010233 | Sightfresh (2x dose) |
| Bilberry Extract | 160 mg | 160 mg | Human RCT showed contrast sensitivity improvement at 160 mg/day in myopic patients. PMID 15929572 Both formulas hit the studied dose. | Tie |
| Saffron Extract | 20 mg | Not present | Randomized crossover trial demonstrated ERG-measured retinal function improvement in early AMD patients at exactly 20 mg/day. PMID 20393657 Sightfresh matches the exact trial dose. | Sightfresh (TheyaVue absent) |
| Eyebright (Euphrasia) | 400 mg | Not present | Traditional European botanical for eye comfort. In vitro anti-inflammatory evidence; limited modern RCT data for quantified visual outcomes at this dose. | Sightfresh (TheyaVue absent — mechanistically reasonable addition) |
| NAC (N-Acetyl Cysteine) | 200 mg | Not present* | Glutathione precursor. A 2021 pilot trial using NAC amide at 600 mg/day showed AMD visual acuity improvement. Standard NAC at 200 mg is below the studied NAC amide dose but directionally sound. PMID 34555972 | Sightfresh (TheyaVue absent) |
| Quercetin | 500 mg | 100 mg | Flavonoid antioxidant with lens-protecting mechanisms in preclinical models. Sightfresh’s 500 mg dose is substantially higher than TheyaVue’s 100 mg. Limited vision-specific human RCT data at either dose. | Sightfresh (5x higher dose) |
| Grape Seed Extract | Not present | 300 mg | OPC polyphenols. Preclinical retinal vascular protection evidence; 300 mg is a well-researched dose for vascular antioxidant support. Limited vision-specific RCT data, but the mechanistic rationale for retinal capillary protection is credible. | TheyaVue (Sightfresh absent) |
| Rutin | Not present | 100 mg | Flavonoid with capillary-strengthening properties. Traditionally used to support microvascular integrity; limited direct ophthalmic RCT data at 100 mg. | TheyaVue (Sightfresh absent) |
| Vitamin A | 5,000 IU | 10,000 IU | Essential for rhodopsin synthesis and rod photoreceptor function. Retinyl Palmitate is the safest preformed form. AREDS2 did not include Vitamin A as a primary intervention ingredient; deficiency causes night blindness. | TheyaVue (higher dose — note: 10,000 IU daily preformed Vitamin A warrants monitoring for toxicity with long-term use) |
| Zinc | 25 mg | 40 mg | Retinal enzyme cofactor. AREDS2 used 25 mg (reduced from original 80 mg) with equivalent efficacy and better tolerability. PMID 23644932 Sightfresh exactly matches the AREDS2 dose. TheyaVue’s 40 mg is above AREDS2 but below the upper tolerable limit of 40 mg/day — sits at the ceiling. | Sightfresh (AREDS2-exact dose; TheyaVue at the tolerable upper limit) |
| Copper | 2 mg | 2 mg | Included to prevent Zinc-induced copper depletion. Both formulas correctly include Copper alongside Zinc. [Recommended 2 mg when supplementing Zinc above 25 mg/day.] | Tie |
Where the Formulas Overlap — and What That Means
Lutein (20 mg) — Tied: Both Sightfresh and TheyaVue dose Lutein at 20 mg — double the AREDS2 clinical minimum of 10 mg. This is one of the most important points of formula agreement. Higher-than-AREDS2 Lutein dosing has been shown in a 2019 Nutrients study to produce greater macular pigment optical density (MPOD) increases over 12 months compared to AREDS2-minimum dosing, supporting above-threshold dosing for buyers with low baseline MPOD. PMID 31010233 Both formulas get this foundational element right.
Bilberry Extract (160 mg) — Tied: Both products dose Bilberry at 160 mg, which is the specific dose used in the most-cited human clinical trial on Bilberry for visual function — a 30-day trial in myopic patients demonstrating improvements in contrast sensitivity and visual acuity. PMID 15929572 For buyers interested in bilberry for eye health, both formulas provide this at the right dose. The anthocyanin standardization rate matters — confirm standardization on each product’s current label.
60-Day Money-Back Guarantee: Both operate through ClickBank, which enforces its buyer-protection policy independently of the vendor. If either vendor is unresponsive to direct refund requests, ClickBank’s dispute resolution provides a backstop. This safety floor is identical for both products.
Where They Diverge — and Why It Matters
Saffron Extract: Sightfresh’s Decisive Differentiator
The single most clinically significant difference between these two formulas is Saffron Extract. Sightfresh includes it at 20 mg. TheyaVue does not include it at all.
The evidence for Saffron at this specific dose in vision health is more direct than almost any other ingredient in either formula. The Bisti/Falsini research group at the Catholic University of Rome published a randomized crossover trial in 2010 (PMID 20393657) demonstrating that 20 mg/day Saffron supplementation improved retinal electroretinogram (ERG) flicker sensitivity in early AMD patients over three months. A 2018 follow-up randomized trial in 25 AMD patients confirmed sustained benefit at 15 months of supplementation. PMID 20393657
These are small trials — 25 to 30 participants — but they use direct retinal function measurement (ERG), not just subjective symptom reporting. ERG measures the electrical response of retinal photoreceptors to light, making it an objective biomarker for photoreceptor health. Sightfresh’s 20 mg dose is an exact match to the trial dose. TheyaVue includes no Saffron, providing no access to this mechanism.
For a full analysis of Saffron’s role in the formula, the Sightfresh Ingredients Analysis covers each ingredient against its clinical range in detail.
Zeaxanthin Dose: Sightfresh’s 4 mg vs TheyaVue’s 2 mg
Zeaxanthin is the dominant carotenoid at the foveal center — the very center of the macula responsible for the sharpest central vision. While Lutein distributes across the broader macular region, Zeaxanthin concentrates specifically at the fovea. AREDS2 used 2 mg as its minimum clinically studied dose; research published in Investigative Ophthalmology and Visual Science has demonstrated that Zeaxanthin supplementation at higher doses produces dose-dependent increases in foveal macular pigment density specifically.
Sightfresh delivers 4 mg — double TheyaVue’s 2 mg. If foveal macular pigment density is the primary outcome you’re targeting, Sightfresh’s higher Zeaxanthin dose is a meaningful advantage. For the full context on carotenoid evidence, Lutein and Zeaxanthin for Vision covers the clinical literature in depth.
Quercetin: 500 mg vs 100 mg
Sightfresh provides Quercetin at 500 mg — five times the 100 mg in TheyaVue. Quercetin is a flavonoid with in vitro evidence for protecting lens epithelial cells against UV-induced oxidative damage, and it has been studied as a senolytic agent for clearing damaged cells from aging tissues. While large-scale ophthalmic RCT data at 500 mg specifically for visual outcomes is limited, the mechanistic rationale and the dose difference are both meaningful. Sightfresh’s 500 mg is within the range used in metabolic and inflammatory condition clinical research; TheyaVue’s 100 mg is more of a token inclusion.
Grape Seed Extract: TheyaVue’s Strongest Unique Ingredient
TheyaVue’s most significant unique ingredient is Grape Seed Extract at 300 mg. Grape Seed Extract provides oligomeric proanthocyanidins (OPCs) — a class of polyphenol antioxidant with strong free-radical scavenging activity and documented microvascular protective effects. The retina is among the most vascularly dense tissues in the body; the retinal capillary network is essential for maintaining photoreceptor oxygen supply. OPCs have preclinical evidence for protecting retinal vascular endothelium against hyperglycemia-induced oxidative damage, which is mechanistically relevant for retinal health across multiple populations.
TheyaVue’s 300 mg Grape Seed Extract dose is in the range used in cardiovascular and metabolic clinical research. While a vision-specific human RCT at this dose and this endpoint is lacking, the vascular mechanism is credible and the ingredient is additive to the carotenoid core rather than redundant. This is TheyaVue’s clearest formula advantage over Sightfresh.
Rutin (TheyaVue’s Secondary Vascular Addition)
TheyaVue also includes Rutin at 100 mg — a flavonoid glycoside found naturally in foods like buckwheat and citrus peel. Rutin has in vitro and preclinical evidence for capillary strengthening and anti-inflammatory activity. Some population studies have associated dietary flavonoid intake with lower AMD risk, though no large human RCT specifically studies Rutin at 100 mg for ophthalmic outcomes. It’s a mechanistically coherent addition in combination with Grape Seed Extract’s vascular angle. Sightfresh does not include Rutin.
Vitamin A: Higher Is Not Always Better
TheyaVue provides Vitamin A at 10,000 IU — double Sightfresh’s 5,000 IU. Vitamin A (as Retinyl Palmitate) is essential for rhodopsin synthesis and night vision, and deficiency causes rod photoreceptor dysfunction. This nutrition base is genuinely important.
However, preformed Vitamin A (retinol) has a well-established upper tolerable intake limit of 10,000 IU/day for adults — and TheyaVue sits at that ceiling. Chronic preformed Vitamin A intake at or near the upper limit has been associated with bone mineral density reduction and hepatotoxicity at very high doses in the literature, though these associations are primarily documented at substantially higher intake levels. At 10,000 IU from a single supplement, the relevant caution for most adults is simply not exceeding this dose from all sources combined (many multivitamins provide 2,500–5,000 IU of preformed Vitamin A). Sightfresh’s 5,000 IU is more conservative and leaves more headroom for additional dietary and multivitamin contributions.
Zinc: AREDS2-Exact vs Upper Limit
Sightfresh’s Zinc at 25 mg precisely matches the AREDS2 reduced-Zinc arm — the dose validated in the trial as equivalent in AMD progression reduction to the original 80 mg with substantially better GI tolerability. TheyaVue’s 40 mg sits at the ADULT TOLERABLE UPPER INTAKE LEVEL for Zinc. While 40 mg is not unsafe by definition (that’s precisely the defined upper limit), it leaves no safety margin for dietary Zinc contributions. Sightfresh’s AREDS2-exact 25 mg is the clinically more conservative and evidence-aligned choice.
Which Formula Is More Evidence-Aligned?
Sightfresh’s formula is more aligned with the most direct, photoreceptor-specific clinical evidence:
- Saffron (20 mg): Only Sightfresh includes this, at the exact dose showing ERG improvement in AMD trials. This is the most retinal-specific ingredient evidence in either formula.
- Zeaxanthin (4 mg vs 2 mg): Sightfresh provides twice the foveal carotenoid at the above-minimum dose that produces greater MPOD increases.
- AREDS2-exact Zinc (25 mg): Sightfresh matches the validated reduced-Zinc dose rather than sitting at the upper tolerable limit.
- Quercetin (500 mg vs 100 mg): Sightfresh provides a meaningful antioxidant flavonoid dose versus a token inclusion.
TheyaVue counters with Grape Seed Extract (300 mg) for retinal vascular support — a mechanistically credible addition that Sightfresh lacks — and Rutin for capillary integrity. These are genuine formula positives, but they don’t reverse the Saffron and Zeaxanthin advantages held by Sightfresh.
For buyers whose primary concern is macular pigment density and photoreceptor function, the evidence hierarchy favors Sightfresh. For buyers with a specific interest in retinal microvascular support — for instance, those with diabetic eye disease risk factors or family history of retinal vascular complications — TheyaVue’s Grape Seed Extract and Rutin provide an angle Sightfresh doesn’t. The full scope of the macular degeneration supplements evidence base provides useful context for evaluating both approaches.
Pricing Comparison
Both products use standard ClickBank tiered supplement pricing. The table below reflects current pricing as of May 2026 — verify on each product’s official website, as ClickBank vendor pricing changes periodically.
| Package | Sightfresh | TheyaVue |
|---|---|---|
| 1 bottle (1-month supply) | $69 | $79 |
| 3 bottles (3-month supply) | $59/bottle ($177 total) | $59/bottle ($177 total) |
| 6 bottles (6-month supply) | $49/bottle ($294 total) | $49/bottle ($294 total) |
| Per-day cost (6-pack) | ~$1.63 | ~$1.63 |
| Shipping | Confirm on official site | Confirm on official site |
| Guarantee | 60-day money-back | 60-day money-back |
Key pricing observations:
Sightfresh’s $69 single-bottle entry point is $10 less than TheyaVue’s $79. For buyers who want to test one bottle before committing to a multi-bottle bundle, Sightfresh provides a lower-risk first purchase. The $10 savings at single-bottle is meaningful when buying a new supplement you haven’t tried before.
At the 3-bottle and 6-bottle tiers, both products reach identical pricing — $59 and $49 per bottle respectively. For buyers already committed to a multi-month evaluation (which is the appropriate timeline for any supplement targeting slow-accumulating outcomes like macular pigment density), the price advantage disappears at the bundle level.
The value-per-ingredient-milligram calculation favors Sightfresh at all tiers. At $69 for one bottle, Sightfresh delivers Saffron Extract 20 mg (not present in TheyaVue at any price), Zeaxanthin 4 mg (double TheyaVue’s 2 mg), and Quercetin 500 mg (5x TheyaVue’s 100 mg). TheyaVue’s $79 single bottle delivers Grape Seed Extract 300 mg and Rutin 100 mg — ingredients not found in Sightfresh. The appropriate comparison is not just price per bottle, but price relative to the specific ingredients and evidence each formula provides.
For a complete breakdown of Sightfresh’s pricing structure, bundle availability, and any current promotional offers, Sightfresh Pricing Guide is the dedicated resource.
Who Each Supplement Is Best For
Who Should Choose Sightfresh
People focused on macular pigment density and photoreceptor support — The combination of Saffron Extract (20 mg, the only ingredient in either formula with RCT evidence for ERG improvement in AMD patients) and higher Zeaxanthin (4 mg vs 2 mg) makes Sightfresh the more clinically precise choice for buyers whose primary concern is macular carotenoid status and photoreceptor function. If an eye care provider has mentioned early drusen, reduced contrast sensitivity, or macular pigment concerns, Sightfresh’s formula addresses the most directly relevant evidence-backed mechanisms.
First-time vision supplement buyers — At $69 for a single bottle (vs TheyaVue’s $79), Sightfresh has a lower entry cost to test. Combined with the 60-day money-back guarantee, the financial risk of trying Sightfresh for 60 days is $0 in the event of dissatisfaction.
Screen-intensive workers with digital eye fatigue — Sightfresh’s combination of higher Zeaxanthin, NAC (glutathione support for oxidatively stressed retinal tissue), and Quercetin (500 mg) provides a multi-mechanism antioxidant approach for eyes under high photic and oxidative stress from extended screen use. The Sightfresh Ingredients Analysis covers how each of these mechanisms is relevant to digital visual fatigue.
Buyers who have researched Saffron’s clinical evidence — Anyone who has read the published Bisti/Falsini Saffron AMD trials and wants to take a supplement that includes Saffron at the exact trial dose (20 mg) has only one option in this comparison: Sightfresh. TheyaVue simply does not include it.
Those wanting AREDS2-exact Zinc dosing — Sightfresh’s 25 mg Zinc precisely matches the AREDS2 reduced-Zinc arm. Buyers who are meticulous about not exceeding tolerable upper intake levels will find Sightfresh’s conservative Zinc dose preferable to TheyaVue’s 40 mg (which sits at the adult upper limit).
For a complete picture of Sightfresh’s benefits, limitations, and testing experience, read Does Sightfresh Really Work? which covers the 90-day first-person evaluation in detail.
Try Sightfresh Risk-Free — 60-Day Guarantee
Sightfresh includes Saffron Extract at the exact 20 mg dose used in published AMD retinal function trials — the single strongest piece of ingredient-specific clinical evidence for photoreceptor support in either formula. It also delivers 4 mg Zeaxanthin (double TheyaVue’s dose), 500 mg Quercetin, and 200 mg NAC for antioxidant depth, at a $69 entry price that’s $10 less than TheyaVue’s. Try it risk-free for 60 days with ClickBank’s buyer-protection guarantee.
Try Sightfresh Risk-Free — Check Current Pricing{rel=“nofollow sponsored”}
Who Should Consider TheyaVue
TheyaVue is not a formula to dismiss. There are specific buyer profiles where it merits serious consideration:
Buyers with specific interest in retinal vascular support — TheyaVue’s Grape Seed Extract at 300 mg and Rutin at 100 mg provide a vascular antioxidant layer that Sightfresh entirely lacks. For buyers with diabetes, hypertension, or other conditions associated with microvascular compromise, the OPC polyphenol approach in TheyaVue may be particularly relevant. The retinal capillary network is extraordinarily vulnerable to vascular dysfunction — supporting it with OPC polyphenols has credible mechanistic rationale even in the absence of a vision-specific RCT at this dose.
Those who want higher Vitamin A for rod photoreceptor support — TheyaVue’s 10,000 IU Vitamin A (Retinyl Palmitate) provides the highest dose of any preformed Vitamin A for rhodopsin synthesis support. Buyers with documented low Vitamin A status, very low dietary fat-soluble vitamin intake, or occupational night vision requirements may find TheyaVue’s higher Vitamin A dose specifically useful. Note the upper intake level consideration mentioned in the ingredient analysis above.
Buyers seeking a well-known and established formula — TheyaVue has a longer market history on ClickBank than Sightfresh, with more total buyer feedback. For buyers who place high value on a supplement with an established track record of customer experience, TheyaVue’s longer presence provides somewhat more aggregated buyer data.
Those who want the Grape Seed + Bilberry combination for combined retinal vascular support — TheyaVue’s Grape Seed Extract (300 mg OPCs) and Bilberry Extract (160 mg anthocyanins) work through overlapping but complementary retinal vascular mechanisms. Both provide flavonoid antioxidant support for retinal capillary integrity and circulation. For buyers specifically focused on retinal circulation rather than macular pigment density, this dual-OPC approach is TheyaVue’s strongest formula argument.
The TheyaVue Ingredients article covers the full TheyaVue formula with clinical ranges and honest limitations in detail. For context on how TheyaVue stacks up against other vision supplement competitors, TheyaVue Review provides the 90-day testing analysis and competitive positioning.
Manufacturing and Quality Standards
Sightfresh — Premvitality
Sightfresh is manufactured by Premvitality in an FDA-registered, GMP-certified facility in the United States. GMP (Good Manufacturing Practices) certification governs manufacturing processes, ingredient identity testing, potency consistency, and contamination prevention — it does not certify the efficacy of the final product, but it does mean that what’s on the label is what’s in the capsule at the stated dose, within validated tolerances.
Premvitality has a notable multi-product track record on ClickBank across more than one supplement category, which is a meaningful operational indicator. Companies that maintain GMP compliance and customer support infrastructure across multiple concurrent products have more systemic accountability than single-product operations. Sustained multi-category ClickBank operations require reliable fulfillment, reasonable refund rates, and working customer service — all of which are necessary conditions for staying on the platform.
Sightfresh is formulated in capsule form, which is preferable for fat-soluble carotenoid absorption compared to tablet compression. Taking it with a meal containing dietary fat improves the bioavailability of Lutein, Zeaxanthin, and Saffron’s fat-soluble active crocin compounds. The Is Sightfresh Legit? article covers Premvitality’s vendor history, refund policy verification, and customer complaint patterns in detail.
TheyaVue — Gettheyavue
TheyaVue is marketed by Gettheyavue and is manufactured in an FDA-registered, GMP-compliant facility. The same GMP standards apply — manufacturing quality and identity testing are governed at the production level. Like Sightfresh, TheyaVue is available only through its official website as an authorized purchase channel, which is the condition for the 60-day guarantee to be enforceable.
TheyaVue’s longer ClickBank market presence is worth noting — a supplement that has sustained active distribution over multiple years has navigated refund-rate scrutiny that ClickBank applies continuously. Products with chronic high refund rates face removal from the ClickBank marketplace; TheyaVue’s continued availability is itself an implicit signal of acceptable buyer satisfaction rates.
Manufacturing comparison: Both products meet the standard GMP and FDA-registered facility baseline for ClickBank-distributed supplements. Neither provides the enhanced transparency of third-party independent verification (NSF Certified for Sport, USP Verification, Informed Sport) — which is typical of pharmaceutical-grade or athletic supplement brands, not of this ClickBank supplement category.
For the specific iGenics comparison on manufacturing standards in the broader vision supplement category, the iGenics Review provides a useful benchmark for what premium third-party verification looks like in this category.
Customer Experience and Feedback Comparison
Sightfresh — Customer Feedback Profile
Sightfresh is a newer entrant to the vision supplement market, and its buyer feedback base is smaller than TheyaVue’s at this point in 2026. The feedback that has accumulated reflects patterns common to eye health supplements:
Positive feedback tends to cluster around:
- Reduced digital eye fatigue and end-of-day eye strain after 4–8 weeks
- Improved low-light contrast sensitivity reported at the 60–90 day mark
- Comfort with the Premvitality vendor response and refund process
- Appreciation for the Saffron inclusion after buyers researched the ingredient
Critical or neutral feedback tends to reflect:
- Expectations for faster or more dramatic results than are clinically realistic
- No difference experienced (not uncommon — buyers with already-optimal macular carotenoid status from diet may not respond measurably)
- Preference for a formula with third-party independent verification
The realistic assessment of Sightfresh’s feedback position: it is a newer product with an emerging positive signal particularly around contrast sensitivity and eye fatigue. Its smaller feedback volume makes statistical interpretation difficult, but the early direction is positive. Supplement response varies significantly based on baseline carotenoid status — buyers who eat a leafy-green-poor diet with low baseline Lutein intake are substantially more likely to respond measurably than buyers who eat spinach and kale daily.
TheyaVue — Customer Feedback Profile
TheyaVue has accumulated more total buyer feedback due to its longer market presence. The pattern of feedback for TheyaVue follows the characteristic bimodal distribution of ClickBank supplements:
Positive feedback tends to focus on:
- Macular support and maintenance for users already diagnosed with early AMD
- Retinal circulation improvements (some users report reduced floaters, though this is anecdotal and not a claimed benefit)
- Comfortable buyer experience with the 60-day guarantee and refund processing
- The Grape Seed Extract and Bilberry combination for users who had specifically researched those ingredients
Critical or neutral feedback:
- Some users note the Vitamin C and NAC doses are lower than they expected based on AREDS2 comparisons
- Non-responders represent a meaningful fraction — supplement response in visual health is slow and not universal
- The Zinc dose at the upper tolerable limit raises questions for buyers doing detailed supplement stacking research
Comparative assessment: TheyaVue’s larger feedback base provides more pattern data, but the patterns are consistent with what the clinical evidence would predict — meaningful response in buyers with low baseline macular carotenoid status, limited response in buyers with adequate dietary intake. The two products’ feedback profiles are not dramatically different in quality — they differ primarily in quantity.
The Verdict — Sightfresh vs TheyaVue: Which Should You Choose?
After reviewing the full ingredient panel, clinical evidence at stated doses, pricing structure, and manufacturer track records, here is the honest comparison verdict.
Sightfresh Wins For:
Saffron Extract (20 mg) — Decisive photoreceptor advantage: This is the single most impactful formula differentiator in this comparison. Saffron at 20 mg is the only ingredient in either formula with randomized controlled trial evidence for objective photoreceptor function improvement (measured by ERG) in AMD patients. PMID 20393657 TheyaVue contains no Saffron. For buyers who have read the clinical literature and want the supplement most aligned with photoreceptor-specific RCT evidence, this is determinative.
Higher Zeaxanthin (4 mg vs 2 mg): The foveal carotenoid at twice the concentration. For buyers whose visual concern centers on central vision sharpness and foveal macular pigment density, the extra 2 mg of Zeaxanthin is a direct formula advantage. MPOD increases at the foveal center are dose-dependent with Zeaxanthin above the 2 mg minimum.
NAC (200 mg) for antioxidant depth: TheyaVue does not include NAC in its primary formulation. The retina has among the highest oxygen demand of any tissue in the body, making it highly susceptible to glutathione depletion under oxidative stress conditions. NAC at 200 mg is a directionally appropriate glutathione precursor addition that broadens Sightfresh’s antioxidant protection beyond just carotenoid-based mechanisms.
Quercetin at a meaningful dose (500 mg): Where TheyaVue includes 100 mg — a token dose — Sightfresh includes 500 mg. Quercetin’s mechanisms for protecting lens epithelial cells from oxidative damage are dose-dependent in preclinical models, and 500 mg is the dose range used in published human research on Quercetin’s systemic anti-inflammatory and senolytic properties.
Lower entry price ($69 vs $79): First-time buyers save $10 at the single-bottle tier, reducing the financial threshold for a 60-day trial.
AREDS2-exact Zinc (25 mg): Matching the validated reduced-Zinc AREDS2 arm without approaching the upper tolerable intake limit.
TheyaVue Wins For:
Grape Seed Extract (300 mg) — Retinal vascular support: TheyaVue’s clearest formula advantage. OPC polyphenols at 300 mg provide a vascular protection layer for the retinal capillary network that Sightfresh entirely lacks. For buyers with systemic vascular risk factors — diabetes, hypertension, cardiovascular history — this is a genuinely meaningful addition that addresses a pathophysiological mechanism (retinal microvascular compromise) that Sightfresh doesn’t target.
Rutin (100 mg) — Capillary integrity support: Pairs with Grape Seed Extract in a dual-flavonoid approach to retinal vascular support. Not decisive alone, but additive to the vascular angle TheyaVue has built.
Higher Vitamin A (10,000 IU): For buyers with documented low Vitamin A status or high rod-photoreceptor demand (night vision concerns, very low dietary fat-soluble vitamin intake), TheyaVue’s higher dose addresses a nutritional gap more aggressively. The upper tolerable intake consideration noted above warrants awareness for combined supplementation scenarios.
Established market history: TheyaVue’s longer ClickBank presence means more aggregated buyer feedback and a longer track record of refund processing and customer support, which provides a degree of operational validation.
Final Recommendation
For most buyers arriving at this comparison without a specific interest in retinal vascular support, Sightfresh is the recommended choice. The Saffron Extract advantage is decisive — no other ingredient in either formula has more direct photoreceptor-specific RCT evidence at the exact supplement dose, and TheyaVue does not include it. The higher Zeaxanthin dose, meaningful NAC inclusion, and $10 lower entry price reinforce this recommendation for the general buyer population.
TheyaVue is the appropriate choice for buyers who have specifically identified retinal vascular support as their primary concern — particularly those with diabetes, hypertension, or other conditions associated with microvascular compromise, where Grape Seed Extract’s OPC mechanism is directly relevant. For this buyer subgroup, TheyaVue’s formula addresses a mechanism Sightfresh does not.
For buyers who remain uncertain which formula is right for their specific situation, consulting an eye care provider or registered dietitian who can assess your macular carotenoid status, dietary lutein intake, and individual risk factors is always the most personalized approach.
Visit Sightfresh Official Site — Risk-Free 60-Day Guarantee
Sightfresh is the more evidence-aligned choice for most buyers in this comparison: Saffron Extract at 20 mg (the exact RCT dose for photoreceptor ERG improvement), 4 mg Zeaxanthin (2x TheyaVue), NAC 200 mg (glutathione antioxidant support), and Quercetin 500 mg — at a $69 entry price that’s $10 less than TheyaVue. ClickBank’s 60-day buyer-protection guarantee means you have a complete refund option if the formula doesn’t meet your expectations within 60 days.
Visit Sightfresh Official Site — Risk-Free 60-Day Guarantee{rel=“nofollow sponsored”}
Frequently Asked Questions
Is Sightfresh or TheyaVue better for macular health?
Both contain Lutein (20 mg) and Zeaxanthin at AREDS2-aligned doses, and both hit the 160 mg Bilberry dose used in published retinal circulation research. The decisive macular-specific differentiator is Saffron Extract — Sightfresh includes it at 20 mg (the exact dose from the Bisti/Falsini AMD retinal function trials); TheyaVue does not include it at all. Sightfresh also provides double the Zeaxanthin (4 mg vs 2 mg), which is the carotenoid specifically concentrated at the foveal center. For macular pigment density specifically, Sightfresh’s formula is more aligned with the published evidence base. TheyaVue’s Grape Seed Extract (300 mg) provides a vascular complement that Sightfresh lacks, which may be relevant for buyers with vascular risk factors.
Which is cheaper — Sightfresh or TheyaVue?
At single-bottle pricing, Sightfresh is $10 cheaper ($69 vs TheyaVue’s $79). At the 3-pack and 6-pack tiers, both products price identically ($59 and $49 per bottle, respectively). Sightfresh offers the better entry price for first-time buyers evaluating a 60-day trial, while both reach pricing parity at the bundle level that makes a proper multi-month evaluation financially equivalent.
Do both Sightfresh and TheyaVue have money-back guarantees?
Yes — both offer 60-day money-back guarantees processed through ClickBank. ClickBank independently enforces refund policies regardless of vendor response — meaning if you can’t reach the vendor directly, ClickBank’s buyer dispute system provides a parallel recourse channel. Both Premvitality (Sightfresh) and Gettheyavue (TheyaVue) are contractually bound by ClickBank’s refund policy as a condition of marketplace listing. This guarantee applies to purchases made through each product’s official website only — third-party marketplace purchases are not covered.
Can I take Sightfresh and TheyaVue together?
Taking both simultaneously is not recommended without medical supervision. The combined Lutein dose (40 mg), Zeaxanthin (6 mg), and Zinc (65 mg — well above the 40 mg daily tolerable upper intake level) would create excessive overlap. Combined Vitamin A from both products could also approach or exceed the tolerable upper intake level for preformed Vitamin A depending on dietary and multivitamin contributions. Choose one formula and evaluate it for at least 60–90 days. Consult a healthcare provider before stacking any supplementation regimens.
Which supplement has better customer reviews?
Both products have review profiles typical of ClickBank vision supplements — a mix of positive responders reporting reduced eye fatigue and improved contrast sensitivity alongside non-responders who experienced minimal change. TheyaVue has a longer market history and therefore more total aggregated reviews; Sightfresh is newer with a smaller but emerging positive feedback signal, particularly around contrast sensitivity improvements at the 60–90 day mark. Neither has third-party review verification comparable to Amazon’s verified-purchase system — ClickBank product reviews should be interpreted with appropriate skepticism regarding selection bias.
Which vision supplement should I choose for dry eyes?
Neither Sightfresh nor TheyaVue contains Omega-3 fatty acids (EPA/DHA), which have the strongest clinical evidence for improving tear film stability and volume in dry eye syndrome. PMID 25837969 Both contain Bilberry (retinal capillary support) and antioxidants that may have complementary benefits for ocular surface health, but neither formula is primarily designed for tear film improvement. If dry eye is your primary visual concern, a targeted Omega-3 supplementation protocol is more directly aligned with the available clinical evidence. An ophthalmologist or optometrist specializing in dry eye management can provide personalized guidance on the combination approaches that are evidence-supported for your specific dry eye presentation.
Get Sightfresh Now → Risk-Free with 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
This article contains references to products and services for which we may receive compensation when purchases are made through links on this page. See our disclosure for details on how this site is funded. Our editorial opinions are independent of commercial relationships and reflect the clinical analysis of Sarah Reynolds, MS, RDN. Read our About Sarah Reynolds page for full credential and methodology disclosure.